# Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

> **NCT06653348** · PHASE2,PHASE3 · RECRUITING · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Ischemic Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Ticagrelor 60 + Aspirin
- **DRUG:** Ticagrelor 90 + aspirin

## Key facts

- **NCT ID:** NCT06653348
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06653348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06653348, "Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06653348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*